PROBLEM: To better understand innate immune responses to sexually-transmitted infection (STI) and the appropriateness of epithelial cell (EC) models of the vaginal and cervical mucosa, quantified toll-like receptor (TLR) expression from a population of women is needed. METHOD OF STUDY: TLR gene expression was quantified in primary and immortalized endocervical, ectocervical, and vaginal EC from multiple donors. TLR bioactivity was evaluated by cytokine elaboration. RESULTS: TLR1-3 and 5-9 were expressed in each EC type with TLR2, 3, 5, 6 and CD14 expressed most abundantly. TLR4 was expressed by endocervical and vaginal EC. Agonist stimulation of TLR2, 3, 5 and 6 elicited cytokines. TLR4 and 7-9 were minimally expressed and were not consistently bioactive. Immortalized EC generally modeled primary cultures but elaborated significantly reduced cytokine levels. CONCLUSION: TLR expression patterns were remarkably conserved across the study population and evaluated tissues indicating a predictable responsiveness to STI. The results support cautious use of immortalized cells for genital tract modeling.
PROBLEM: To better understand innate immune responses to sexually-transmitted infection (STI) and the appropriateness of epithelial cell (EC) models of the vaginal and cervical mucosa, quantified toll-like receptor (TLR) expression from a population of women is needed. METHOD OF STUDY: TLR gene expression was quantified in primary and immortalized endocervical, ectocervical, and vaginal EC from multiple donors. TLR bioactivity was evaluated by cytokine elaboration. RESULTS: TLR1-3 and 5-9 were expressed in each EC type with TLR2, 3, 5, 6 and CD14 expressed most abundantly. TLR4 was expressed by endocervical and vaginal EC. Agonist stimulation of TLR2, 3, 5 and 6 elicited cytokines. TLR4 and 7-9 were minimally expressed and were not consistently bioactive. Immortalized EC generally modeled primary cultures but elaborated significantly reduced cytokine levels. CONCLUSION: TLR expression patterns were remarkably conserved across the study population and evaluated tissues indicating a predictable responsiveness to STI. The results support cautious use of immortalized cells for genital tract modeling.
Authors: Lyndsey R Buckner; Danny J Schust; Jian Ding; Takeshi Nagamatsu; Wandy Beatty; Theresa L Chang; Sheila J Greene; Maria E Lewis; Bernardo Ruiz; Stacey L Holman; Rae Ann Spagnuolo; Richard B Pyles; Alison J Quayle Journal: J Reprod Immunol Date: 2011-09-22 Impact factor: 4.054
Authors: Mathanraj Packiam; Roshan D Yedery; Afrin A Begum; Russell W Carlson; Jhuma Ganguly; Gregory D Sempowski; Melissa S Ventevogel; William M Shafer; Ann E Jerse Journal: Infect Immun Date: 2014-03-31 Impact factor: 3.441
Authors: A C Hearps; D Tyssen; D Srbinovski; L Bayigga; D J D Diaz; M Aldunate; R A Cone; R Gugasyan; D J Anderson; G Tachedjian Journal: Mucosal Immunol Date: 2017-04-12 Impact factor: 7.313
Authors: Chris L McGowin; Andrea L Radtke; Kyle Abraham; David H Martin; Melissa Herbst-Kralovetz Journal: J Infect Dis Date: 2013-03-14 Impact factor: 5.226
Authors: Chris L McGowin; Rochelle S Annan; Alison J Quayle; Sheila J Greene; Liang Ma; Miriam M Mancuso; David Adegboye; David H Martin Journal: Infect Immun Date: 2012-08-20 Impact factor: 3.441